Pancreatic Cancer Research

ResearcherTohoku UniversityActive in the last 2 years

Tetsuya Takikawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6214-7337; OpenAlex author ID A5073897869. Sources: OpenAlex.

Their work

Papers
16 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2012: 1 paper · 2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 5 papers

Papers 16

  1. Mortality and cancer risk in patients with chronic pancreatitis in japan: insights into the importance of surveillance for pancreatic cancer. Co-author DOI 10.1007/s00535-025-02321-0↗
  2. Pancreatic cancer: An urgent clinical challenge and opportunities for improved care. First author DOI 10.1016/j.pan.2025.11.009↗
  3. Utility of longitudinal changes in CA19-9 for detection of pancreatic ductal adenocarcinoma in patients with benign pancreatic diseases. First author DOI 10.1016/j.pan.2026.10.007↗
  4. Type I Collagen Increases Survivin Expression in Pancreatic Cancer Cells. Co-author DOI 10.1620/tjem.2026.j084↗
  5. Diabetes Trajectory and Pancreatic Cancer Detection in Patients with Diabetes: A Nationwide Survey Through Japan Diabetes Society-Certified Facilities. Co-author DOI 10.3390/cancers18182995↗
  6. Clinical features and prognostic impact of asymptomatic pancreatic cancer. Co-author DOI 10.1038/s41598-022-08083-6↗
  7. Senescent Human Pancreatic Stellate Cells Secrete CXCR2 Agonist CXCLs to Promote Proliferation and Migration of Human Pancreatic Cancer AsPC-1 and MIAPaCa-2 Ce… Co-author DOI 10.3390/ijms23169275↗
  8. Focal Parenchymal Atrophy of the Pancreas Is Frequently Observed on Pre-Diagnostic Computed Tomography in Patients with Pancreatic Cancer: A Case-Control Study. First author DOI 10.3390/diagnostics11091693↗
  9. New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer. Co-author DOI 10.1620/tjem.252.353↗
  10. Focal Parenchymal Atrophy and Fat Replacement Are Clues for Early Diagnosis of Pancreatic Cancer with Abnormalities of the Main Pancreatic Duct. Co-author DOI 10.1620/tjem.252.63↗
  11. Exosomes derived from pancreatic cancer cells induce activation and profibrogenic activities in pancreatic stellate cells. Co-author DOI 10.1016/j.bbrc.2017.10.141↗
  12. Kindlin-2 in pancreatic stellate cells promotes the progression of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2017.01.008↗
  13. Exosomes Derived From Pancreatic Stellate Cells: MicroRNA Signature and Effects on Pancreatic Cancer Cells. Co-author DOI 10.1097/mpa.0000000000000722↗
  14. miR-210 regulates the interaction between pancreatic cancer cells and stellate cells. Co-author DOI 10.1016/j.bbrc.2013.06.097↗
  15. The angiotensin II type I receptor blocker olmesartan inhibits the growth of pancreatic cancer by targeting stellate cell activities in mice. Co-author DOI 10.3109/00365521.2013.777776↗
  16. Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells. Co-author DOI 10.1016/j.bbrc.2012.04.014↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Atsushi Masamune · 14 shared papers, 2012–2026 · strength 1.78
  2. Shin Hamada · 13 shared papers, 2012–2026 · strength 1.49
  3. Ryotaro Matsumoto · 8 shared papers, 2020–2026 · strength 1.41
  4. Kazuhiro Kikuta · 10 shared papers, 2012–2026 · strength 1.38
  5. Naoki Yoshida · 8 shared papers, 2013–2022 · strength 0.73
  6. Shin Miura · 6 shared papers, 2013–2026 · strength 0.71
  7. Michiaki Unno · 5 shared papers, 2017–2026 · strength 0.63
  8. Yasuhisa Mori · 1 shared paper, 2026 · strength 0.50
  9. Takao Ohtsuka · 1 shared paper, 2026 · strength 0.50
  10. Fumiya Kataoka · 3 shared papers, 2021–2022 · strength 0.42
  11. Tooru Shimosegawa · 6 shared papers, 2012–2018 · strength 0.37
  12. Naoko Hozumi · 1 shared paper, 2026 · strength 0.28
  13. Shuichi Aoki · 1 shared paper, 2026 · strength 0.23
  14. Toshiaki Abe · 1 shared paper, 2026 · strength 0.23
  15. Masahiro Iseki · 2 shared papers, 2020 · strength 0.19
  16. Kei Nakagawa · 1 shared paper, 2022 · strength 0.13
  17. Toru Furukawa · 1 shared paper, 2020 · strength 0.09
  18. Fuyuhiko Motoi · 1 shared paper, 2017 · strength 0.07
  19. Masayoshi Kobune · 1 shared paper, 2012 · strength 0.03
  20. Kennichi Satoh · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.